
Indonesia's richest woman, Marina Budiman, experienced a staggering financial setback as her net worth dropped by half within just three days. The dramatic decline was triggered by a sharp fall in the stock value of her company, PT Kalbe Farma Tbk, one of Indonesia's largest pharmaceutical firms.
Marina Budiman, who inherited her wealth from her father, the late Boenjamin Setiawan, founder of Kalbe Farma, saw her fortune shrink significantly as the company's shares plummeted. The sudden drop in stock value has raised concerns among investors and market analysts about the stability of the pharmaceutical giant and the broader Indonesian stock market.
Kalbe Farma, a leading player in Southeast Asia's healthcare industry, has been a cornerstone of Indonesia's economy for decades. However, recent market volatility and external economic pressures have contributed to the company's declining share price.
The loss of half her wealth in such a short period underscores the unpredictable nature of financial markets, even for the wealthiest individuals. Marina Budiman's situation serves as a reminder of the risks associated with high-stakes investments and the fragility of personal fortunes tied to stock performance.
As the situation unfolds, market watchers are closely monitoring Kalbe Farma's next steps and whether the company can recover from this significant financial blow. For Marina Budiman, the rapid decline in her net worth marks a challenging chapter in her otherwise successful business legacy.